These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28139284)

  • 1. French Jardé's law and European regulation on drug trials: Harmonization and implementation of new rules.
    Deplanque D; Sénéchal-Cohen S; Lemaire F;
    Therapie; 2017 Feb; 72(1):73-80. PubMed ID: 28139284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting trafficking of falsified and substandard medicinal products in Russia.
    Fayzrakhmanov NF
    Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Trials Legislation - preparing for the revision of the European Directive Scheduled for 2011.
    Bilbault P; Belorgey C; Zannad F; Golinelli D; Pletan Y;
    Therapie; 2010; 65(4):301-8, 291-9. PubMed ID: 20854751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The adoption of Jardé law modifies the legal framework of clinical research in France].
    Maillols-Perroy AC; Tillet Y
    Therapie; 2012; 67(2):77-87. PubMed ID: 22850095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Impact of the Jardé's law on research management].
    Bernhard JC; Latxague C
    Prog Urol; 2017 May; 27(6):334-336. PubMed ID: 28483484
    [No Abstract]   [Full Text] [Related]  

  • 6. [French regulation of medical research].
    Michaud M; Michaud Peyrot C
    Rev Med Interne; 2020 Feb; 41(2):98-105. PubMed ID: 31898997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reorganization of the procedures and the tasks of the responsible ethics committees after the 12th AMG amendment. Concepts of the permanent working group of the medical ethics committees in Germany].
    Wessler I; Burger R; Doppelfeld E
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):155-67. PubMed ID: 15726456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recording and reporting adverse reactions in clinical trials. New legal provisions according to the 12th Law Amending the German Drug Law (AMG) and the Ordinance on GCP (GCP-V)].
    Eckhardt K; Cremer-Schaeffer P; König J; Paeschke N
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):173-80. PubMed ID: 15726458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Opinion of the French National Academy of Medicine on the legislative framework for the application of the European Directive on biomedical research in humans].
    Rouëssé J
    Bull Acad Natl Med; 2003; 187(5):1001-15. PubMed ID: 14979061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The European "clinical trial" regulation; relationship with the Jardé Act: a Giens workshop.
    Lemaire F; Marchenay B; Chassany O; ; Barthélémy P; Bouzzagou M; Comet D; Delval C; Dubray C; Fouret C; Frija-Orvoen E; Gambotti L; Lamarque V; d'Orsay G; Plattner V; Sibenaler C; Roux J; Thoby F
    Therapie; 2015; 70(1):21-36. PubMed ID: 25679191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The conduct of clinical trials for medicinal products in europe in the light of the European clinical trials directive. Review of regulatory and practical aspects in the different countries.
    Dubray C; Maillere P; Spriet A;
    Therapie; 2007; 62(3):193-7, 199-202. PubMed ID: 17803885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Harmonisation of regulatory requirements for clinical trials on medicinal products for human use in the Directive 2001/20/EC and complementary guidance. Implementation of the 12th Law Amending the German Drug Law].
    Geisler I; Hofmann HP; Nickel L
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 Feb; 48(2):141-6. PubMed ID: 15726454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Trial Application in Europe: What Will Change with the New Regulation?
    Giannuzzi V; Altavilla A; Ruggieri L; Ceci A
    Sci Eng Ethics; 2016 Apr; 22(2):451-66. PubMed ID: 26037896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical trials for medicinal products. New European and national legal rules].
    Kreutz G
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2005 May; 48(5):524-9. PubMed ID: 15887061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creating conditions for the success of the French industrial advanced therapy sector.
    Lirsac PN; Blin O; Magalon J; ; Angot P; de Barbeyrac E; Bilbault P; Bourg E; Damour O; Faure P; Ferry N; Garbil B; Larghero J; Nguon M; Pattou F; Thumelin S; Yates F
    Therapie; 2015; 70(1):69-94. PubMed ID: 25747840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of the European Clinical Trials Directive on academic clinical research.
    Baeyens AJ
    Med Law; 2004; 23(1):103-10. PubMed ID: 15163079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Does clinical research provide any "direct individual benefit"?].
    Lemaire F
    Med Sci (Paris); 2004 Feb; 20(2):244-7. PubMed ID: 14997448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishing pan-European clinical trials: regulatory compliance and other practical considerations.
    Grienenberger A
    J Biolaw Bus; 2004; 7(4):58-63. PubMed ID: 15675097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A proposal for reforming psychologists' training in France and in the European Union].
    Bouchard JP
    Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.